期刊文献+

地塞米松与尿激酶联合应用注入胸腔治疗大鼠结核性胸膜炎的实验研究 被引量:5

暂未订购
导出
摘要 目的探讨地塞米松与尿激酶联合应用注入大鼠胸腔对结核性胸膜炎疗效的影响。方法将60只SD大鼠根据体质量按随机数字表法分为A、B、C组3组,每组20只。建立结核性胸膜炎后,A组大鼠右侧胸腔内注入地塞米松+尿激酶,B组注入尿激酶,C组注入等量的生理盐水。在24、72 h及5、7 d观察并记录各组大鼠排液量、肺功能、胸膜厚度和黏连情况。结果 24、72 h胸腔积液量A组高于B组、B组高于C组(均P<0.05),7 d后胸腔积液量A组少于B组和C组(P均<0.05)。24 h后胸膜厚度A组低于B组(P<0.01),B组低于C组(P<0.01)。肺功能指标方面,PEF A组优于B组(P<0.05),B组优于C组(P<0.01),FEV0.3 A组优于B组(P<0.05),B组优于C组(P<0.01)。5、7 d时胸腔粘连评分A组优于B组,B组优于C组(均P<0.05)。结论大鼠胸腔内联合注入尿激酶与地塞米松的效果优于单独注射等剂量的尿激酶。
出处 《实用临床医学(江西)》 CAS 2013年第8期12-13,25,共3页 Practical Clinical Medicine
  • 相关文献

参考文献5

二级参考文献20

  • 1Antomy VB, Repine JB, Harada RV, et al. Inflammatory responses in experimental tuberculosis pleurisy. Acta Cytologica, 1983, 27:355 -361.
  • 2Serbina N, Flynn J. Early emergence of CD8^+ T cells primed forproduction of type 1 cytokines in the lungs of mycobacterium tuberculosis -infected mice. Infect Immun,1999, 67:3980-3988.
  • 3Tumer J, Corrah T, Sabbally S,et al. A longitudinal study of in vitro IFN-γ production and cytotoxic T cell responses of tuberculosis patients in the Gambia. Tuber Lung Dis ,2000,80 : 161-169.
  • 4Hussain R, Kaleem A, Shahid F, et al. Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J Immunol Methods, 2002, 264:95-108.
  • 5Marisol HG, Patricia MS. Transforming growth factor-β1 decreases survival of mycobacterium bovis-activated T cells. Arch Med Res,2003,34:20-25.
  • 6Aoe K, Hiraki A, Murakami T, et al. Diagnostic significance of interferon-gamma in tuberculous pleural effusions. Chest,2003,123 :740 -744.
  • 7Melis M, Pace E, Siena L, et al. Biologically active intercellular adhesion molecule-1 in shed as dimers by a regulated mechanism in the inflamed pleural space. Am J Respir Care Med, 2003, 167:1131-1138.
  • 8Sprenger A, Schardt C, Rotsch M, et al. Soluble intercellular adhesion molecule-1 in patients with lung cancer and benign lung diseases. J Cancer Res Clin Onco1,1997,123:632-638.
  • 9Klein JS,Schultz S,Heffner JE.Interventional radiology of the chest: image-guided percutaneous drainage of pleural effusions,lung abscess,and pneumothorax.Am J Roentgenol,1995,164:581-588.
  • 10金关甫 见:张敦熔 主编.结核性胸膜炎[A].见:张敦熔,主编.现代结核病学[C].北京:人民军医出版社,2002.262-263.

共引文献87

同被引文献47

  • 1Kim SY,Oh TH,Sen JY,et al.A case of tuberculous peritonitis developed during chemotherapy for tuberculous pleurisy as paradoxical response[J].Korean J Gastroenterol,2011,57(6):379-383.
  • 2ORDONEZ A A, MAIGA M, GUPTA S, et al. Novel adjunctive therapies for the treatment of tuberculosis [ J ]. Curr Mol Med, 2014,14 (3) :385-395.
  • 3JEON D. Tuberculous pleurisy : an update [ J ]. Tuberc Respir Dis (Seoul) ,2014,76(4) : 153-159.
  • 4LIGHT R W. Update on tuberculous pleural effusion [ J ]. Re- spirology,2010,15 (3) :451-458.
  • 5VILLENA GARRIDO V, CASES VIEDMA E, FERNANDEZ VILLAR A, et al. Recommendations of diagnosis and treatment of pleural effusion. Update [ J 1. Arch Bronconeumol, 2014,50 (6) :235-249.
  • 6THORLUND K,IMBERGER G,JOHNSTON B C,et al. Evolution of heterogeneity (I2) estimates and their 95% confidence inter- vals in large meta-analyses[J]. PI_oS One,2012,7(7) :e39471.
  • 7WANG J, XIAO L, CHEN J, et al. Potential effectiveness of traditional Chinese medicine for cardiac syndrome X (CSX) : a systematic review and meta- analysis [ J ]. BMC Complemen- tary Alter Med,2013,13( 1 ) :62.
  • 8TONG A,FLEMMING K,MCINNES E,et al. Enhancing trans- parency in reporting the synthesis of qualitative research:EN- TREQ[ J]. BMC Med Res Methodol,2012,12 : 181.
  • 9周建国,刘育明,王融江.微创置管引流联合地塞米松、尿激酶治疗结核性胸腔积液临床分析[J].实用临床医学(江西),2009,10(10):31-33. 被引量:2
  • 10李卫民.尿激酶加地塞米松治疗结核性渗出性胸膜炎的疗效观察[J].内蒙古中医药,2010,29(10):77-77. 被引量:2

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部